Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer

NCT02455141 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

786

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: Epirubicin plus Cyclophosphamide
DRUG: Taxanes
DRUG: Taxanes plus Carboplatin

Sponsor

Shanghai Jiao Tong University School of Medicine